-
Turoctocog alfa in the treatment of individuals with hemophilia A: review of quality of life data collected in Phase III trials
Stephanie Seremetis, Roshni Kulkarni, Antoine Regnault & Elena Santagostino
Review: Clinical Trail Outcomes: Clinical Investigation
-
Turoctocog alfa in the treatment of individuals with hemophilia A: review of quality of life data collected in Phase III trials
Stephanie Seremetis, Roshni Kulkarni, Antoine Regnault & Elena Santagostino
Review: Clinical Trail Outcomes: Clinical Investigation
-
Turoctocog alfa in the treatment of individuals with hemophilia A: review of quality of life data collected in Phase III trials
Stephanie Seremetis, Roshni Kulkarni, Antoine Regnault & Elena Santagostino
Review: Clinical Trail Outcomes: Clinical Investigation
-
Turoctocog alfa in the treatment of individuals with hemophilia A: review of quality of life data collected in Phase III trials
Stephanie Seremetis, Roshni Kulkarni, Antoine Regnault & Elena Santagostino
Review: Clinical Trail Outcomes: Clinical Investigation
-
Turoctocog alfa in the treatment of individuals with hemophilia A: review of quality of life data collected in Phase III trials
Stephanie Seremetis, Roshni Kulkarni, Antoine Regnault & Elena Santagostino
Review: Clinical Trail Outcomes: Clinical Investigation
-
Turoctocog alfa in the treatment of individuals with hemophilia A: review of quality of life data collected in Phase III trials
Stephanie Seremetis, Roshni Kulkarni, Antoine Regnault & Elena Santagostino
Review: Clinical Trail Outcomes: Clinical Investigation
-
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Special Issue Article: Clinical Investigation
-
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Special Issue Article: Clinical Investigation
-
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Special Issue Article: Clinical Investigation
-
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Special Issue Article: Clinical Investigation
-
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Special Issue Article: Clinical Investigation
-
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Special Issue Article: Clinical Investigation
-
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
New therapeutics for pulmonary arterial hypertension: do gene therapies have translational values?
Roxane Paulin, Marjorie Barrier, Sebastien Bonnet
Editorial: Clinical Investigation
-
New therapeutics for pulmonary arterial hypertension: do gene therapies have translational values?
Roxane Paulin, Marjorie Barrier, Sebastien Bonnet
Editorial: Clinical Investigation
-
New therapeutics for pulmonary arterial hypertension: do gene therapies have translational values?
Roxane Paulin, Marjorie Barrier, Sebastien Bonnet
Editorial: Clinical Investigation
-
New therapeutics for pulmonary arterial hypertension: do gene therapies have translational values?
Roxane Paulin, Marjorie Barrier, Sebastien Bonnet
Editorial: Clinical Investigation
-
New therapeutics for pulmonary arterial hypertension: do gene therapies have translational values?
Roxane Paulin, Marjorie Barrier, Sebastien Bonnet
Editorial: Clinical Investigation
-
New therapeutics for pulmonary arterial hypertension: do gene therapies have translational values?
Roxane Paulin, Marjorie Barrier, Sebastien Bonnet
Editorial: Clinical Investigation
-
Will preoperative trials change future clinical practice?
Elgene Lima,Eric P Winer
Review Article: Clinical Investigation
-
Will preoperative trials change future clinical practice?
Elgene Lima,Eric P Winer
Review Article: Clinical Investigation
-
Will preoperative trials change future clinical practice?
Elgene Lima,Eric P Winer
Review Article: Clinical Investigation
-
Will preoperative trials change future clinical practice?
Elgene Lima,Eric P Winer
Review Article: Clinical Investigation
-
Will preoperative trials change future clinical practice?
Elgene Lima,Eric P Winer
Review Article: Clinical Investigation
-
Will preoperative trials change future clinical practice?
Elgene Lima,Eric P Winer
Review Article: Clinical Investigation